NCT03565666View on ClinicalTrials.gov

The Insulin-Only Bionic Pancreas Bridging Study

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

July 9, 2018

Primary Completion Date

November 19, 2018

Study Completion Date

November 19, 2018

Conditions
Type1 Diabetes Mellitus
Interventions
DEVICE

iLet Bionic Pancreas insulin-only configuration with Humalog or Novolog

iLet Bionic Pancreas insulin-only configuration with Humalog or Novolog

DRUG

iLet Bionic Pancreas insulin-only configuration with Fiasp

iLet Bionic Pancreas insulin-only configuration with Fiasp (faster insulin aspart)

OTHER

Usual care

Usual care

Trial Locations (3)

32207

Nemours Children's Specialty Care, Jacksonville

80045

Barbara Davis Center for Childhood Diabetes, Aurora

94305

Stanford University, Palo Alto

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT03565666 - The Insulin-Only Bionic Pancreas Bridging Study | Biotech Hunter | Biotech Hunter